ALS (Amyotrophic Lateral Sclerosis, a.k.a. Lou Gehrig’s disease) is is a rare but serious neurodegenerative condition that gradually causes muscle weakness and loss of control, eventually impacting the ability to move, speak, and breathe. It affects around 20,000-30,000 people in the U.S. at any time, with most cases diagnosed between ages 40 and 70.
Current ALS treatments are limited by a focus on symptom management and lack of understanding of the disease’s cause, but new technologies like 3D printing can offer exciting opportunities for innovation, such as custom prosthetics, artificial muscles, tissue engineering, and personalized medicine, which could significantly improve patient outcomes.
Continue Reading